Drug intelligence / Profile preview

Compound Danshen Tablets

Development stage
Phase 4
Lead developer
Tasly Holding Group
Modality
Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Compound Danshen Tablets (Fufang Danshen Pian) is a traditional Chinese herbal formulation developed and manufactured by Beijing Tong Ren Tang. It is composed of three primary herbal ingredients: Danshen (*Salvia miltiorrhiza*), Sanqi (*Panax notoginseng*), and Borneol (*Bingpian*). This oral formulation is traditionally used to promote blood circulation, remove blood stasis, regulate qi, and alleviate pain. Its primary clinical indications include the relief of chest tightness and the support of cardiovascular health, particularly in conditions associated with coronary heart disease. As a traditional herbal compound, it functions through the synergistic effects of its botanical constituents according to Traditional Chinese Medicine (TCM) principles rather than a single defined molecular target.

Brand names
Compound Danshen TabletsFufang Danshen Pian
Other names
複方丹參片Fufang Danshen Pian
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)CYP2J2 (Cytochrome P450 family 2 subfamily J member 2)CYP3A7 (Cytochrome P450 3A7)IL-6 (Interleukin 6)TP53 (Cellular Tumor Antigen p53 R175H)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Compound Danshen Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compound Danshen Tablets.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call